Dr. Lolic joined FDA in 2008 as a clinical reviewer in the Office of New Drugs. She was involved in approvals of new drugs, improvement of post-marketing drug safety databases, and regulatory training for medical officers. Dr. Lolic is currently leading the Drug Trials Snapshot initiative. Her work focuses on demographics of clinical trial participants and variability in drug response among demographic subgroups.
Dr. Lolic received her medical and master’s degrees from University of Belgrade, Yugoslavia. She completed a research fellowship at George Washington University and an internal medicine residency at Greater Baltimore Medical Center, where she served as Chief resident. Dr. Lolic is a board-certified internist and prior to joining FDA, she was practicing hospitalist at University of Maryland St. Joseph Medical Center in Towson, Maryland.